CopyMark Law Group
4.9/5
Drawing for CYTORA

USPTO serial 99858153

CYTORA

Reviewed by CopyMark Law Group

Status 630
Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with CYTORA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Roy D. Gross

Roy D. Gross The Roy Gross Law Firm, LLC19 Old Kings Hwy SSuite 200Darien, CT 06820

Goods and services

ClassDescriptionStatusFirst use
001Stem cells for cosmetic purposes; secretome derived from stem cells for cosmetic purposes; naïve and modified exosomes derived from stem cells for cosmetic purposes.ACTIVE—
005Stem cells for medical purposes; stem cells for veterinary purposes; stem cells for use in regenerative medicine; secretome derived from stem cells for medical purposes; secretome derived from stem cells for veterinary purposes; secretome derived from stem cells for use in regenerative medicine; naïve and modified exosomes derived from stem cells for medical purposes; naïve and modified exosomes derived from stem cells for veterinary purposes; naïve and modified exosomes derived from stem cells for use in regenerative medicine.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 1, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 1, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance